• Extractables portal
  • BioPhorum membership
  • Contact us
  • WebsiteLog in
  • Home
  • Phorums
    • Cell & Gene Therapy
    • Development Group
    • Drug Substance
    • Fill Finish
    • Information Technology
    • MedTech
    • Regulatory
    • Supply Partner
    • Sustainability
    • Technology Roadmapping
  • Industry priorities
    • Buffer stock blending system
    • Change notification
    • Closure playbook
    • Cyber security
    • Digital integration of sponsor and contract organizations
    • Digital plant maturity model
    • Extractables and leachables
    • Forecast and demand planning
    • In-Line Monitoring and Real-Time Release
    • IT for cell and gene therapies
    • Knowledge management
    • Lab of the future
    • Raw materials
    • Single-use systems
    • Sterile Filtration QRM & PUPSIT
    • Technology adoption
  • About
    • About BioPhorum
    • Deliverables Report
    • Webinars and Podcasts
    • BioPhorum publications
    • External collaborations
    • Leadership
    • BioPhorum membership
    • Work with us
    • Review for BioPhorum
    • Legals
  • BioPhorum Home
  • Phorums
    • Cell & Gene Therapy
    • Development Group
    • Drug Substance
    • Fill Finish
    • Information Technology
    • MedTech
    • Regulatory
    • Supply Partner
    • Sustainability
    • Technology Roadmapping
  • Industry priorities
    • Buffer stock blending system
    • Change Notification
    • Closure playbook
    • Cyber security
    • Digital integration of sponsor and contract organizations
    • Digital plant maturity model
    • Extractables and leachables
    • Forecast and demand planning
    • In-Line Monitoring and Real-Time Release
    • IT for cell and gene therapies
    • Knowledge Management
    • Lab of the future
    • Raw materials
    • Single-use systems
    • Sterile Filtration QRM & PUPSIT
  • BioPhorum directory
  • Extractables Portal
  • About
    • BioPhorum Deliverables report
    • Webinars and Podcasts
    • External collaborations
    • Leadership
    • External collaborations
    • Membership
    • Work with us
    • Review for BioPhorum
    • Legals
  • Contact us
NIIMBL Roadmaps: 1. Vaccines: 2. Antibody-Drug Conjugates (ADC) and Bi-specific Antibodies: 3. Gene Therapies

NIIMBL Roadmaps: 1. Vaccines: 2. Antibody-Drug Conjugates (ADC) and Bi-specific Antibodies: 3. Gene Therapies

by Tony White | Nov 13, 2018

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) collaborated with BioPhorum to create and publish three technology roadmaps to complement Biophorum’s Biomanufacturing Technology Roadmap published in 2017. The roadmaps developed in a...

Follow Us

  • Facebook
  • LinkedIn
  • Twitter

Contact address

BioPhorum
The Gridiron Building
One Pancras Square
London
N1C 4AG

Phorums

  • Cell & Gene Therapy
  • Development Group
  • Drug Substance
  • Fill Finish
  • Information Technology
  • MedTech
  • Supply Partner
  • Sustainability
  • Technology Roadmapping
  • Regulatory

Newsletter subscribe

Enter your E-mail address to receive our monthly newsletter direct to your inbox.

This field is for validation purposes and should be left unchanged.

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

© 2019 BioPhorum Operations Group · All Rights Reserved
Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ
Company Number 06794795 · VAT Number GB298617544

Privacy Policy
Designed and Powered by Powerloop Ltd.

[ Placeholder content for popup link ] WordPress Download Manager - Best Download Management Plugin